Our findings of upregulated CK2α correlate with defective mitophagy (where CK2α phosphorylates FUNDC1 at Ser [13] to inactivate mitophagy [22]) in MASLD patients and HFD‐fed mice. The gene discussed is FUNDC1; the disease is metabolic dysfunction-associated steatotic liver disease.